Non-small Cell Lung Cancer Therapeutics Market Report

Global and China Non-small Cell Lung Cancer Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 17, 2022
  • PAGES：159
  • REPORT CODE：GMM1383017
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Non-small Cell Lung Cancer Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sanofi

    • Bristol-Myers Squibb

    • AstraZeneca

    • Roche

    • Novartis

    • Pfizer

    • Eli Lilly

    • GlaxoSmithKline

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Alimta

    • Iressa

    • Avastin

    • Tarceva

    • Zykadia

    • Tagrisso

    • Xalkori

    • Cyramza

    • Opdivo

    • Alecensa

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Non-small Cell Lung Cancer Therapeutics Industry Overview

      • 1.1.1 Non-small Cell Lung Cancer Therapeutics Market Scope and Market Segments

      • 1.1.2 Non-small Cell Lung Cancer Therapeutics Industry Characteristics

      • 1.1.3 Global and China Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Non-small Cell Lung Cancer Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Alimta

      • 1.2.2 Iressa

      • 1.2.3 Avastin

      • 1.2.4 Tarceva

      • 1.2.5 Zykadia

      • 1.2.6 Tagrisso

      • 1.2.7 Xalkori

      • 1.2.8 Cyramza

      • 1.2.9 Opdivo

      • 1.2.10 Alecensa

    • 1.3 Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Non-small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Non-small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Non-small Cell Lung Cancer Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Non-small Cell Lung Cancer Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Non-small Cell Lung Cancer Therapeutics Industry PEST Analysis

    • 2.3 Non-small Cell Lung Cancer Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Non-small Cell Lung Cancer Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Non-small Cell Lung Cancer Therapeutics Industry

    Chapter 3 Global and China Non-small Cell Lung Cancer Therapeutics Market, by Manufacturer

    • 3.1 Global and China Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Non-small Cell Lung Cancer Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Non-small Cell Lung Cancer Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Non-small Cell Lung Cancer Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Non-small Cell Lung Cancer Therapeutics Market Top 3 Players

    Chapter 4 Global and China Non-small Cell Lung Cancer Therapeutics Market, by Type (2017-2028)

    • 4.1 Non-small Cell Lung Cancer Therapeutics Market Trend, by Type

    • 4.2 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Non-small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Non-small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Non-small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Non-small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Non-small Cell Lung Cancer Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Non-small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Non-small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Non-small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Non-small Cell Lung Cancer Therapeutics Market Analysis

    • 7.1 North America Non-small Cell Lung Cancer Therapeutics Market, by Type

    • 7.2 North America Non-small Cell Lung Cancer Therapeutics Market, by Application

    • 7.3 North America Non-small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Non-small Cell Lung Cancer Therapeutics Market Analysis

    • 8.1 Europe Non-small Cell Lung Cancer Therapeutics Market, by Type

    • 8.2 Europe Non-small Cell Lung Cancer Therapeutics Market, by Application

    • 8.3 Europe Non-small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Non-small Cell Lung Cancer Therapeutics Market Analysis

    • 9.1 APAC Non-small Cell Lung Cancer Therapeutics Market, by Type

    • 9.2 APAC Non-small Cell Lung Cancer Therapeutics Market, by Application

    • 9.3 APAC Non-small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Non-small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Non-small Cell Lung Cancer Therapeutics Company Profiles

      • 11.1 Sanofi

        • 11.1.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sanofi Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Sanofi Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Bristol-Myers Squibb

        • 11.2.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 AstraZeneca

        • 11.3.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Roche

        • 11.4.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Roche Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Roche Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Novartis

        • 11.5.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Novartis Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Novartis Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Eli Lilly

        • 11.7.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 GlaxoSmithKline

        • 11.8.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.8.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Non-small Cell Lung Cancer Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Non-small Cell Lung Cancer Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Non-small Cell Lung Cancer Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Alimta (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Iressa (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Avastin (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Tarceva (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Zykadia (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Tagrisso (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Xalkori (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Cyramza (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Opdivo (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Alecensa (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Non-small Cell Lung Cancer Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Non-small Cell Lung Cancer Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Non-small Cell Lung Cancer Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Non-small Cell Lung Cancer Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Non-small Cell Lung Cancer Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Value, by Type (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Value, by Application (2017-2028)

    • Table China Non-small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Non-small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Non-small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Non-small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Non-small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Non-small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Non-small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Non-small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US